Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer.

Colavito SA, Platt JT, Held MA, Liu Z, Sokup R, Stern DF.

Oncotarget. 2019 Aug 6;10(47):4822-4839. doi: 10.18632/oncotarget.27104. eCollection 2019 Aug 6.

2.
3.

NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53.

Wilson KA, Colavito SA, Schulz V, Wakefield PH, Sessa W, Tuck D, Stern DF.

Mol Cancer Res. 2011 Jun;9(6):766-81. doi: 10.1158/1541-7786.MCR-10-0317. Epub 2011 May 6.

4.

Genetic composition of the Bacillus subtilis SOS system.

Au N, Kuester-Schoeck E, Mandava V, Bothwell LE, Canny SP, Chachu K, Colavito SA, Fuller SN, Groban ES, Hensley LA, O'Brien TC, Shah A, Tierney JT, Tomm LL, O'Gara TM, Goranov AI, Grossman AD, Lovett CM.

J Bacteriol. 2005 Nov;187(22):7655-66.

5.

Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation.

Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR.

Nat Genet. 2004 Mar;36(3):257-63. Epub 2004 Feb 8. Erratum in: Nat Genet. 2004 Apr;36(4):427. Nat Genet. 2005 Mar;37(3):328.

PMID:
14770183

Supplemental Content

Loading ...
Support Center